$Vor Biopharma (VOR.US)$ Is there any good news? 😘

$Vor Biopharma (VOR.US)$
Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design
• Preliminary data suggests improved relapse-free survival compared to published groups of acute myeloid leukemia (AML) patients at high risk of relapse post-transplant
• Trem-cel + Mylotarg continue to demonstrate engraftment, shielding, and broadened therapeutic window
...

Hey, mooers!
$NVIDIA (NVDA.US)$ released the Q2 FY25 results on August 28 after the bell. The overall data is strong and still hit a new record high. However, the Q3 revenue guidance fell short of the highest optimistic expectations, which triggered a huge after-hours shock in the stock market and ultimately regrettable to the end of the day with the decline of more than 6%.
What are the key highlights of the earnings report? Unlock insights with NVDA Earnings Hub>>
...

$Warrior Met Coal (HCC.US)$ Need the RS line (blue in the main chart) to break through the previous high (currently a significant gap)
$Oscar Health (OSCR.US)$Price needs to be further compressed to reduce risk ratio
$Constellation Energy (CEG.US)$In terms of chart patterns, everything looks good at the moment
$Applovin (APP.US)$ Need a closer correlation between prices, when breaking through, RS and prices should be synchronized
$Micron Technology (MU.US)$ Currently, the chart pattern is only halfway complete, more consolidation is still needed
$NVIDIA (NVDA.US)$ Starting from March 8th, excluding small distribution days, there are currently 5 large distribution days. The fundamentals are almost unbeatable, but it still needs a long time to consolidate.
$Viking Therapeutics (VKTX.US)$ Need to see a closer chart. Currently, RS is already leading price (a good sign). It is difficult to find a low-risk entry point within a range (stop loss). It's worth waiting for an opportunity to try.
$Dell Technologies (DELL.US)$ The RS line is currently good, but it needs a closer chart.
$Vertiv Holdings (VRT.US)$ The financial risk has already passed, with the RS line leading by a wide margin, it needs some time to digest the overextended 50MA...

$Taiwan Semiconductor (TSM.US)$ saw the volume on its $150 call options explode after the world's largest contract chipmaker reported an almost 60% jump in net revenue in April, fueling optimism over the prospects of the company and the rest of the industry.
The stock surged 5% to $149.865 at 12:02 p.m. in New York Friday. The rally ignited trading on call options that give the holder the right to buy shares at $150 ea...